Sanara MedTech appoints Elizabeth Taylor as CFO, McNeil as Chief Accounting Officer & CAO
Sanara MedTech Inc.
Elizabeth Taylor appointed CFO effective Jan 15, 2025; base salary $250,000, eligible for annual restricted stock award up to 75% of salary and cash bonus up to 75% of salary.
Michael McNeil assumes roles of Chief Accounting Officer and Chief Administrative Officer; base salary increased to $234,000, bonus eligibility raised to up to 75% of salary.
Taylor joins from Imbed Biosciences where she served as CFO; holds MBA from Harvard and BA from Princeton.
Both executive employment agreements include severance provisions: one year base salary, accelerated stock vesting, and COBRA reimbursement upon qualifying termination.
On January 15, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Elizabeth B. Taylor to serve as the Chief Financial Officer of the Company, including the role of principal financial officer, effective as of the Effective Date.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Elizabeth B. Taylor was appointed as Chief Financial Officer at Sanara MedTech Inc..
Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On January 15, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Sanara MedTech Inc. (the “Company”) appointed Elizabeth B. Taylor to serve as the Chief Financial Officer of the Company, including the role of principal financial officer, effective as of the Effective Date.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.